29.09USD-5.23%Mkt Cap: 547.11M USDP/E: —Last update: 2026-06-01
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe tech…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap547.11M USD
Enterprise Value357.40M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-74.15M USD
Revenue/Share—
Last Price29.09 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees60
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.66
PEG—
EV/EBITDA-3.90
EV/Revenue—
P/S—
P/B2.32
EPS (TTM)-4.46
EPS (Forward)-4.68
52W Range
14.3968% of range36.03
52W High36.03 USD
52W Low14.39 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-29.50%
ROA-28.41%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-60.08M USD
CapEx (TTM)208.00K USD
FCF Margin—
FCF Yield-8.17%
Net Debt-232.26M USD
Net Debt/EBITDA2.53
Balance Sheet
Debt/Equity0.01
Current Ratio18.51
Quick Ratio18.28
Book Value/Sh13.41 USD
Cash/Share12.55 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:12
Split DateJun 21, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)78.44 USD
Target Range60.00 USD – 101.00 USD
# Analysts9
Ownership
Shares Out.18.87M
Float11.23M
Insiders39.34%
Institutions74.13%
Short Interest
Short Ratio10.9d
Short % Float29.06%
Short % Out.13.84%
Shares Short2.61M
Short (prev mo.)2.43M
Technical
SMA 5029.26 (-0.6%)
SMA 20022.72 (+28.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)226.37K
Avg Vol (10d)230.67K
Technical Indicators
RSI (14)58.2
MACD0.3073
MACD Signal0.0327
MACD Hist.+0.2746
BB Upper30.96 USD
BB Middle28.86 USD
BB Lower26.76 USD
BB Width14.54%
ATR (14)1.802 USD
Vol Ratio (20d)1.00x